BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ameen R, Sanad N, Al-Shemmari S, Siddique I, Chowdhury RI, Al-Hamdan S, Al-Bashir A. Prevalence of viral markers among first-time Arab blood donors in Kuwait. Transfusion. 2005;45:1973-1980. [PMID: 16371052 DOI: 10.1111/j.1537-2995.2005.00635.x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Mohamoud YA, Riome S, Abu-Raddad LJ. Epidemiology of hepatitis C virus in the Arabian Gulf countries: Systematic review and meta-analysis of prevalence. Int J Infect Dis. 2016;46:116-125. [PMID: 26996460 DOI: 10.1016/j.ijid.2016.03.012] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 7.0] [Reference Citation Analysis]
2 Specialist Panel on Chronic Hepatitis B in the Middle East. A review of chronic hepatitis B epidemiology and management issues in selected countries in the Middle East. J Viral Hepat. 2012;19:9-22. [PMID: 22187943 DOI: 10.1111/j.1365-2893.2011.01511.x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 2.8] [Reference Citation Analysis]
3 Zamani F, Sohrabi M, Poustchi H, Keyvani H, Saeedian FS, Ajdarkosh H, Khoonsari M, Hemmasi G, Moradilakeh M, Motamed N, Maadi M. Prevalence and risk factors of hepatitis C virus infection in amol city, north of iran: a population-based study (2008-2011). Hepat Mon 2013;13:e13313. [PMID: 24358039 DOI: 10.5812/hepatmon.13313] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
4 Zampino R, Boemio A, Sagnelli C, Alessio L, Adinolfi LE, Sagnelli E, Coppola N. Hepatitis B virus burden in developing countries. World J Gastroenterol 2015; 21(42): 11941-11953 [PMID: 26576083 DOI: 10.3748/wjg.v21.i42.11941] [Cited by in CrossRef: 107] [Cited by in F6Publishing: 96] [Article Influence: 17.8] [Reference Citation Analysis]
5 Chehadeh W, Kurien SS, Abdella N, Ben-Nakhi A, Al-Arouj M, Almuaili T, Al-Mutairi O, Al-Nakib W. Hepatitis C virus infection in a population with high incidence of type 2 diabetes: impact on diabetes complications. J Infect Public Health. 2011;4:200-206. [PMID: 22000848 DOI: 10.1016/j.jiph.2011.05.004] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.9] [Reference Citation Analysis]
6 Narciso-Schiavon JL, Schiavon Lde L, Carvalho-Filho RJ, Emori CT, Maryia FA, Bordin JO, Silva AE, Ferraz ML. Clinical and epidemiological profile of female blood donors with positive serology for viral hepatitis B. Rev Soc Bras Med Trop 2015;48:524-31. [PMID: 26516960 DOI: 10.1590/0037-8682-0157-2015] [Reference Citation Analysis]
7 Allain JP, Sibinga CT. Family donors are critical and legitimate in developing countries. Asian J Transfus Sci 2016;10:5-11. [PMID: 27011664 DOI: 10.4103/0973-6247.164270] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 4.4] [Reference Citation Analysis]
8 Mahmud S, Kouyoumjian SP, Al Kanaani Z, Chemaitelly H, Abu-Raddad LJ. Individual-level key associations and modes of exposure for hepatitis C virus infection in the Middle East and North Africa: a systematic synthesis. Ann Epidemiol 2018;28:452-61. [PMID: 29661680 DOI: 10.1016/j.annepidem.2018.03.007] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
9 Abu-Raddad LJ, Hilmi N, Mumtaz G, Benkirane M, Akala FA, Riedner G, Tawil O, Wilson D. Epidemiology of HIV infection in the Middle East and North Africa. AIDS. 2010;24 Suppl 2:S5-23. [PMID: 20610949 DOI: 10.1097/01.aids.0000386729.56683.33] [Cited by in Crossref: 96] [Cited by in F6Publishing: 86] [Article Influence: 9.6] [Reference Citation Analysis]
10 Altawalah H, Essa S, Ezzikouri S, Al-Nakib W. Hepatitis B virus, hepatitis C virus and human immunodeficiency virus infections among people who inject drugs in Kuwait: A cross-sectional study. Sci Rep 2019;9:6292. [PMID: 31000775 DOI: 10.1038/s41598-019-42810-w] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
11 Kafi-abad SA, Rezvan H, Abolghasemi H, Talebian A. Prevalence and trends of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus among blood donors in Iran, 2004 through 2007. Transfusion 2009;49:2214-20. [PMID: 19527477 DOI: 10.1111/j.1537-2995.2009.02245.x] [Cited by in Crossref: 57] [Cited by in F6Publishing: 59] [Article Influence: 4.8] [Reference Citation Analysis]
12 Mitrovic N, Delic D, Markovic-Denic L, Jovicic M, Popovic N, Bojovic K, Simonovic Babic J, Svirtlih N. Seroprevalence and risk factors for hepatitis C virus infection among blood donors in Serbia: A multicentre study. Dig Liver Dis 2015;47:572-6. [PMID: 25882212 DOI: 10.1016/j.dld.2015.03.019] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
13 Ben Jemia R, Gouider E. Seroprevalency of transfusion-transmitted infections in first-time volunteer and replacement donors in Tunisia. Transfus Clin Biol 2014;21:303-8. [PMID: 25458983 DOI: 10.1016/j.tracli.2014.10.001] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
14 Kumari S. Prevalence and trends of hepatitis B virus, Hepatitis C virus, Human immunodeficiency virus 1, 2 and syphilis infections among blood donors in a regional transfusion center in Punjab, India: A 3 years study. Indian J Sex Transm Dis AIDS 2020;41:22-9. [PMID: 33062977 DOI: 10.4103/0253-7184.196887] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
15 Ashkani-Esfahani S, Alavian SM, Salehi-Marzijarani M. Prevalence of hepatitis C virus infection among hemodialysis patients in the Middle-East: A systematic review and meta-analysis. World J Gastroenterol 2017; 23(1): 151-166 [PMID: 28104991 DOI: 10.3748/wjg.v23.i1.151] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 15] [Article Influence: 5.5] [Reference Citation Analysis]
16 Alavian S, Tabatabaei S, Mahboobi N. Epidemiology and risk factors of HCV infection among hemodialysis patients in countries of the Eastern Mediterranean Regional Office of WHO (EMRO): a quantitative review of literature. J Public Health 2011;19:191-203. [DOI: 10.1007/s10389-010-0366-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
17 Abedi F, Madani H, Asadi A, Nejatizadeh A. Significance of blood-related high-risk behaviors and horizontal transmission of hepatitis B virus in Iran. Arch Virol 2011;156:629-35. [PMID: 21229276 DOI: 10.1007/s00705-010-0902-y] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
18 Daw MA, Dau AA. Hepatitis C virus in Arab world: a state of concern. Sci World J. 2012;2012:719494. [PMID: 22629189 DOI: 10.1100/2012/719494] [Cited by in Crossref: 31] [Cited by in F6Publishing: 44] [Article Influence: 3.4] [Reference Citation Analysis]
19 Mousavi T, Haghshenas MR, Rafiei A, Navaei RA, Khah ZH. Hepatitis B Virus Genotypes Distribution with HBsAg Positive in the North of Iran (Mazandaran) During 2011-2014. Med Arch 2014;68:376-80. [PMID: 25648402 DOI: 10.5455/medarh.2014.68.376-380] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
20 Kafi-abad SA, Rezvan H, Abolghasemi H. Trends in prevalence of hepatitis B virus infection among Iranian blood donors, 1998-2007. Transfus Med 2009;19:189-94. [PMID: 19708860 DOI: 10.1111/j.1365-3148.2009.00935.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
21 Ramia S, Melhem NM, Kreidieh K. Hepatitis C virus infection in the Middle East and North Africa “MENA” region: injecting drug users (IDUs) is an under-investigated population. Infection. 2012;40:1-10. [PMID: 22237470 DOI: 10.1007/s15010-011-0236-z] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
22 Esmat G, Raziky M, El-kassas M, Hassany M, Gamil ME. Treatment of Chronic HCV Genotype 4 Infection. Curr Hepatitis Rep 2012;11:250-5. [DOI: 10.1007/s11901-012-0146-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
23 Saad MF, Alenezi S, Asker H; Kuwait Hepatology Club. Expert opinion on the management of hepatitis C infection in Kuwait. Hepat Med. 2018;10:117-132. [PMID: 30319294 DOI: 10.2147/hmer.s154842] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
24 Liu Y, Wu F. Global burden of aflatoxin-induced hepatocellular carcinoma: a risk assessment. Environ Health Perspect. 2010;118:818-824. [PMID: 20172840 DOI: 10.1289/ehp.0901388] [Cited by in Crossref: 559] [Cited by in F6Publishing: 439] [Article Influence: 50.8] [Reference Citation Analysis]
25 Babanejad M, Izadi N, Najafi F, Alavian SM. The HBsAg Prevalence Among Blood Donors From Eastern Mediterranean and Middle Eastern Countries: A Systematic Review and Meta-Analysis. Hepat Mon 2016;16:e35664. [PMID: 27226804 DOI: 10.5812/hepatmon.35664] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 3.6] [Reference Citation Analysis]
26 Cruz JR. Reduction of maternal mortality: the need for voluntary blood donors. Int J Gynaecol Obstet 2007;98:291-3. [PMID: 17374536 DOI: 10.1016/j.ijgo.2007.01.020] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
27 El-Nabi SH, El-Garawani I, Ismail F, Abdelsameea E. Anti-HBc and hepatitis B virus DNA among HBsAg-negative blood donors from the main central blood bank units in Eastern Libya. Transfus Med 2020;30:401-5. [PMID: 32894893 DOI: 10.1111/tme.12711] [Reference Citation Analysis]
28 Alhajeri H, Abutiban F, Al-Adsani W, Al-Awadhi A, Aldei A, AlEnizi A, Alhadhood N, Al-Herz A, Alkandari W, Dehrab A, Muhanna Ghanem AA, Hasan E, Hayat S, Saleh K, Tarakmeh H, Ali Y. Kuwait association of rheumatology 2018 treatment recommendations for patients with rheumatoid arthritis. Rheumatol Int 2019;39:1483-97. [PMID: 31309293 DOI: 10.1007/s00296-019-04372-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
29 Mohamoud YA, Miller FD, Abu-Raddad LJ. Potential for human immunodeficiency virus parenteral transmission in the Middle East and North Africa: An analysis using hepatitis C virus as a proxy biomarker. World J Gastroenterol 2014; 20(36): 12734-12752 [PMID: 25278675 DOI: 10.3748/wjg.v20.i36.12734] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.9] [Reference Citation Analysis]
30 Song Y, Bian Y, Petzold M, Ung CO. Prevalence and trend of major transfusion-transmissible infections among blood donors in Western China, 2005 through 2010. PLoS One 2014;9:e94528. [PMID: 24714490 DOI: 10.1371/journal.pone.0094528] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 5.4] [Reference Citation Analysis]
31 Al-Sadeq DW, Taleb SA, Zaied RE, Fahad SM, Smatti MK, Rizeq BR, Al Thani AA, Yassine HM, Nasrallah GK. Hepatitis B Virus Molecular Epidemiology, Host-Virus Interaction, Coinfection, and Laboratory Diagnosis in the MENA Region: An Update. Pathogens 2019;8:E63. [PMID: 31083509 DOI: 10.3390/pathogens8020063] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
32 Gasim GI. Hepatitis B virus in the Arab world: where do we stand? Arab J Gastroenterol. 2013;14:35-43. [PMID: 23820498 DOI: 10.1016/j.ajg.2013.04.002] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
33 Al-Rubaye A, Tariq Z, Alrubaiy L. Prevalence of hepatitis B seromarkers and hepatitis C antibodies in blood donors in Basra, Iraq. BMJ Open Gastroenterol 2016;3:e000067. [PMID: 26966550 DOI: 10.1136/bmjgast-2015-000067] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
34 Mousavi T, Ziabakhsh-Tabary S, Ghaemiyan A, Haghshenas MR. Prevalence and genotypes of hepatitis B virus infection in patients underwent coronary angiography and coronary artery bypass grafting in mazandaran heart center, sari, iran. Med Arch 2014;68:320-4. [PMID: 25568563 DOI: 10.5455/medarh.2014.68.320-324] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
35 Al Awaidy ST, Ezzikouri S. Moving towards hepatitis B elimination in Gulf Health Council states: From commitment to action. J Infect Public Health 2020;13:221-7. [PMID: 31445879 DOI: 10.1016/j.jiph.2019.08.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
36 Al-Awadhi R, Al-Harmi J, Alfadhli S. Prevalence of cytomegalovirus DNA in cord blood and voided urine obtained from pregnant women at the end of pregnancy. Med Princ Pract. 2013;22:194-199. [PMID: 23075743 DOI: 10.1159/000343167] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
37 Sharma M, Al Kaabi S, John AK, Al Dweik N, Ullah Wani H, Babu Thandassary R, Derbala MF, Al Ejji K, Sultan K, Pasic F, Al Mohannadi M, Yacoub R, Butt MT, Singh R. Screening for hepatitis C in average and high-risk populations of Qatar using rapid point-of-care testing. United European Gastroenterol J 2015;3:364-70. [PMID: 26279845 DOI: 10.1177/2050640615580725] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]